Valuation: ChronoScale Corporation

Market Cap 2.64B 2.32B 2.13B 1.99B 3.75B 251B 3.83B 25.67B 9.94B 123B 9.91B 9.7B 429B P/E 2024 *
-
P/E 2025 -
Enterprise Value 2.86B 2.51B 2.31B 2.15B 4.06B 272B 4.14B 27.78B 10.76B 133B 10.73B 10.5B 464B EV / Sales 2024 *
-
EV / Sales 2025 2.71x
Free-Float
2.43%
Yield 2024 *
-
Yield 2025 -
1 day-20.61%
1 week-20.29%
Current month-20.61%
1 month+3.95%
3 months+65.63%
6 months+104.17%
Current year+104.17%
1 week 17.54
Extreme 17.545
23.52
1 month 15.53
Extreme 15.5337
28.2
Current year 6.93
Extreme 6.93
28.2
1 year 2.91
Extreme 2.9078
28.2
3 years 2.73
Extreme 2.73
46.93
5 years 2.73
Extreme 2.73
82.35
10 years 2.73
Extreme 2.73
1,527.98
Date Insider Type Main position Quantity % Market Cap.
06-28Free

Director

200,000 0.1377%
05-13Free

Director

200,000 2.8063%
05-13Free

Director

109,357 1.5345%
Change 5-day change 1-year change 3-year change Capi.($)
-20.61%-20.29%+420.35%-17.76% 2.54B
+2.39%+4.29%+21.80%-1.61% 191B
+1.18%+0.14%-25.21%+17.68% 143B
+1.70%+2.57%-3.67%-19.28% 137B
+0.89%-3.15%-58.90%-20.39% 64B
+1.69%+2.60%+19.19%-2.48% 52.97B
-1.54%+0.73%-26.51%-33.51% 43.82B
+0.42%+1.34%+10.74%+10.93% 37.67B
+0.82%+2.42%+5.91%+41.87% 37.13B
+1.33%-0.03%-14.60%-20.16% 29.5B
Average -1.17%-0.03%+34.91%-4.47% 73.8B
Weighted average by Cap. +1.32%+3.29%-3.51%-2.73%

Financials

*1 *
Net sales - -
Net income - -
Net Debt - -
Logo ChronoScale Corporation
ChronoScale Corporation, formerly Ekso Bionics Holdings, Inc., designs, develops, and markets exoskeleton products. Its exoskeleton technology serves people with physical disabilities or impairments in both physical rehabilitation and mobility. The Company operates as one segment with two markets: Enterprise Health and Personal Health. Its products include EksoNR, which is a wearable robotic exoskeleton designed for a rehabilitation setting; Ekso Indego Therapy is a modular, adjustable, lightweight, lower limb-powered exoskeleton; Ekso Indego Personal is a lower limb orthosis; Ekso Nomad is a power Knee Ankle Foot Orthosis, and Ekso EVO is a wearable upper body exoskeleton. It enables individuals with neurological conditions affecting gait, including acquired brain injury (ABI) and spinal cord injury (SCI), to rehabilitate, stand and walk again. It assists people to perform challenging repetitive tasks for extended periods.
Employees
-
Date Price Change Volume
26-07-01 US$17.64 -20.61% 807,653
26-06-30 US$22.22 -2.80% 220,796
26-06-29 US$22.86 +2.83% 150,760
26-06-26 US$22.23 -1.24% 314,356
26-06-25 US$22.51 +1.72% 479,985
  1. Stock Market
  2. Stocks
  3. CHRN Stock